Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBI Dose De-escalation in Fanconi Anemia Transplant
NCT00352976Phase 3Completed
- Sponsor
- Masonic Cancer Center
- Start
- May 2006
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of fludarabine, cyclophosphamide in Fanconi anemia (FA), sponsored by Masonic Cancer Center. Started May 2006; status: completed.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT00352976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352976.